Robert R. Webb
10Patents
4h-index
12Co-inventors
57Inventor score
Filing activity: Dec 21, 1998 → Feb 20, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6887861B1 | Compounds for intracellular delivery of therapeutic moieties to nerve cells | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6652864B1 | Compounds for intracellular delivery of therapeutic moieties to nerve cells | Human Necessities | 19 | Expired |
| US7678378B2 | Compounds for intracellular delivery of therapeutic moieties to nerve cells | Emerging Cross-Sectional Technologies | 15 | Expired |
| US7718605B2 | Compounds for intracellular delivery of therapeutic moieties to nerve cells | Emerging Cross-Sectional Technologies | 15 | Active |
| US6664241B2 | Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof | Human Necessities | 3 | Expired |
| US8138155B2 | Compounds for intracellular delivery of therapeutic moieties to nerve cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US10568872B2 | Antifungal compounds | Human Necessities | 0 | Active |
| US9956207B2 | Antifungal compounds | Human Necessities | 0 | Active |
| US8232251B2 | Compounds for delivery of therapeutic and imaging moieties to nerve cells | Human Necessities | 0 | Active |
| US11000514B2 | Antifungal compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.